Xintela AB (FRA:1XT) Accounts Payable : €0.47 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Xintela AB Accounts Payable?

Xintela AB's Accounts Payable for the quarter that ended in Sep. 2024 was €0.47 Mil.

Xintela AB's quarterly Accounts Payable declined from Mar. 2024 (€0.47 Mil) to Jun. 2024 (€0.43 Mil) but then increased from Jun. 2024 (€0.43 Mil) to Sep. 2024 (€0.47 Mil).

Xintela AB's annual Accounts Payable increased from Dec. 2021 (€0.67 Mil) to Dec. 2022 (€0.81 Mil) but then declined from Dec. 2022 (€0.81 Mil) to Dec. 2023 (€0.67 Mil).

Xintela AB Accounts Payable Historical Data

The historical data trend for Xintela AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB Accounts Payable Chart

Xintela AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.36

0.27

0.67

0.81

0.67

Xintela AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															0.42	0.67	0.47	0.43	0.47

Xintela AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Xintela AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Xintela AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (FRA:1XT) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

XINT:Sweden

Address

Medicon Village, Lund, SWE, 22381

Website

https://www.xintela.se

Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.

Xintela AB Headlines

No Headlines